U.S. Markets close in 2 hrs 58 mins
  • S&P 500

    3,859.30
    -40.81 (-1.05%)
     
  • Dow 30

    31,226.03
    -212.23 (-0.68%)
     
  • Nasdaq

    11,312.33
    -212.22 (-1.84%)
     
  • Russell 2000

    1,763.48
    -8.26 (-0.47%)
     
  • Crude Oil

    111.85
    +2.28 (+2.08%)
     
  • Gold

    1,822.10
    -2.70 (-0.15%)
     
  • Silver

    20.84
    -0.33 (-1.55%)
     
  • EUR/USD

    1.0526
    -0.0060 (-0.5684%)
     
  • 10-Yr Bond

    3.1920
    -0.0020 (-0.06%)
     
  • Vix

    27.32
    +0.37 (+1.37%)
     
  • GBP/USD

    1.2196
    -0.0074 (-0.6049%)
     
  • USD/JPY

    136.1810
    +0.7350 (+0.5427%)
     
  • BTC-USD

    20,703.89
    -37.60 (-0.18%)
     
  • CMC Crypto 200

    450.46
    +0.40 (+0.09%)
     
  • FTSE 100

    7,323.41
    +65.09 (+0.90%)
     
  • Nikkei 225

    27,049.47
    +178.17 (+0.66%)
     

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Avid Bioservices, Inc
Avid Bioservices, Inc

TUSTIN, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year ended April 30, 2022 on June 29, 2022 after market close and will host a conference call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time). Members of Avid's senior management will discuss financial results for the quarter and FY ended April 30, 2022 and review recent corporate developments.

To listen to the live webcast, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.

To listen to the conference call, please dial (877) 312-5443 or (253) 237-1126 and request the Avid Bioservices call.

About Avid Bioservices, Inc.

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 29 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

CONTACT: Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@vidasp.com